SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-067205
Filing Date
2005-03-31
Accepted
2005-03-31 16:59:29
Documents
9
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT d10k.htm 10-K 1196241
2 CONSENT OF ERNST & YOUNG, LLP dex231.htm EX-23.1 1540
3 CEO CERTIFICATION dex311.htm EX-31.1 8878
4 CFO CERTIFICATION dex312.htm EX-31.2 8877
5 SECTION 906 CERTIFICATION dex321.htm EX-32.1 3854
6 SECTION 906 CERTIFICATION dex322.htm EX-32.2 3827
7 GRAPHIC g89301g14o31.jpg GRAPHIC 79709
8 GRAPHIC g89301g68b48.jpg GRAPHIC 71921
9 GRAPHIC g89301g93g78.jpg GRAPHIC 79199
  Complete submission text file 0001193125-05-067205.txt   1456387
Mailing Address
Business Address 1124 COLUMBIA STREET SUITE 130 SEATTLE WA 98104 2062626200
XCYTE THERAPIES INC (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50626 | Film No.: 05721384
SIC: 2834 Pharmaceutical Preparations